Literature DB >> 17135272

Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation.

Xue Wang1, Yong Wang, Hong Pyo Kim, Kiichi Nakahira, Stefan W Ryter, Augustine M K Choi.   

Abstract

Hyperoxia causes cell injury and death associated with reactive oxygen species formation and inflammatory responses. Recent studies show that hyperoxia-induced cell death involves apoptosis, necrosis, or mixed phenotypes depending on cell type, although the underlying mechanisms remain unclear. Using murine lung endothelial cells, we found that hyperoxia caused cell death by apoptosis involving both extrinsic (Fas-dependent) and intrinsic (mitochondria-dependent) pathways. Hyperoxia-dependent activation of the extrinsic apoptosis pathway and formation of the death-inducing signaling complex required NADPH oxidase-dependent reactive oxygen species production, because this process was attenuated by chemical inhibition, as well as by genetic deletion of the p47(phox) subunit, of the oxidase. Overexpression of heme oxygenase-1 prevented hyperoxia-induced cell death and cytochrome c release. Likewise, carbon monoxide, at low concentrations, markedly inhibited hyperoxia-induced endothelial cell death by inhibiting cytochrome c release and caspase-9/3 activation. Carbon monoxide, by attenuating hyperoxia-induced reactive oxygen species production, inhibited extrinsic apoptosis signaling initiated by death-inducing signal complex trafficking from the Golgi apparatus to the plasma membrane and downstream activation of caspase-8. We also found that carbon monoxide inhibited the hyperoxia-induced activation of Bcl-2-related proteins involved in both intrinsic and extrinsic apoptotic signaling. Carbon monoxide inhibited the activation of Bid and the expression and mitochondrial translocation of Bax, whereas promoted Bcl-X(L)/Bax interaction and increased Bad phosphorylation. We also show that carbon monoxide promoted an interaction of heme oxygenase-1 with Bax. These results define novel mechanisms underlying the antiapoptotic effects of carbon monoxide during hyperoxic stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17135272     DOI: 10.1074/jbc.M607610200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.

Authors:  Ahmed A Elmarakby; Jessica Faulkner; Mohammed Al-Shabrawey; Mong-Heng Wang; Krishna Rao Maddipati; John D Imig
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

2.  Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia.

Authors:  Angeles Fernandez-Gonzalez; S Alex Mitsialis; Xianlan Liu; Stella Kourembanas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

3.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  A single dose of carbon monoxide intraperitoneal administration protects rat intestine from injury induced by lipopolysaccharide.

Authors:  Shao-Hua Liu; Ke Ma; Xin-Rong Xu; Bing Xu
Journal:  Cell Stress Chaperones       Date:  2010-03-27       Impact factor: 3.667

5.  Haem oxygenase: a model for therapeutic intervention.

Authors:  Gregory J Quinlan; Anna L Lagan; Timothy W Evans
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

6.  Maternal active and passive smoking and hypertensive disorders of pregnancy: risk with trimester-specific exposures.

Authors:  Stephanie M Engel; Erica Scher; Sylvan Wallenstein; David A Savitz; Elin R Alsaker; Lill Trogstad; Per Magnus
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

Review 7.  Carbon monoxide in the treatment of sepsis.

Authors:  Kiichi Nakahira; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-23       Impact factor: 5.464

Review 8.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

9.  Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes.

Authors:  Susan Cheng; Danielle Enserro; Vanessa Xanthakis; Lisa M Sullivan; Joanne M Murabito; Emelia J Benjamin; Joseph F Polak; Christopher J O'Donnell; Philip A Wolf; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2014-02-25       Impact factor: 29.983

10.  Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Firas S Zetoune; J Vidya Sarma; Clement M Werner; Guido A Wanner; Hans-Peter Simmen; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.